Other Hematopoietic

5 protocols meet the specified criteria.

  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

  • A211901

    Reaching Rural Cancer Survivors Who Smoke Using Test-Based Cessation Interventions

  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)

  • GRAIL-MA-002

    REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH/Galleri-Medicare study)

  • WVU020924

    Phase I/II study of leflunomide in combination with decitabine for treatment of relapsed or refractory myelodysplastic syndromes